We will be initiating and participating in multi-disciplinary studies through the Group. These funds will support our continued efforts in cooperative clinical trials investigating surgery, radiotherapy, chemotherapy and combined modality treatment in breast, lung, testicular bladder, prostate, and head and neck cancers as well as malignant lymphomas, myelomas and leukemia. Indiana University will continue to provide leadership in the development and pursuit of group studies. The newly-enlarged hematology staff will extend the treatment of hematological malignancies at IUMC. Indiana will continue to develop local investigations which may lead to group-wide SCSG studies. Indiana University expects to increase its number of patient accessions and its use of multi-modality studies. IUMC members will act as project chairmen and committee members and otherwise contribute to the success of the Group. The major goals of these studies are improved patient care, prolonged survival, and rapidly assimilated clinical data. In addition, participation in Group work will expose our medical students, housestaff, and fellows to multi-disciplinary group protocols that will exemplify the epitome of patient management and stress a multi-modal approach to the patient with neoplastic disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10CA028171-06S1
Application #
3556911
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1980-08-01
Project End
1987-07-31
Budget Start
1985-08-01
Budget End
1987-07-31
Support Year
6
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
Schools of Medicine
DUNS #
005436803
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Johnson, D H; Bass, D; Einhorn, L H et al. (1993) Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. J Clin Oncol 11:1223-9
Loehrer Sr, P J (1992) Chronic oral etoposide: trials at Indiana University and with the Hoosier Oncology Group. Semin Oncol 19:48-52
Luedke, D W; Einhorn, L; Omura, G A et al. (1990) Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial. J Clin Oncol 8:886-91
Johnson, D H; Einhorn, L H; Bartolucci, A et al. (1990) Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 113:33-8
Einhorn, L H; Williams, S D; Loehrer, P J et al. (1989) Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol 7:387-91
Lyss, A P; Luedke, S L; Einhorn, L et al. (1989) Vindesine and mitomycin C in metastatic breast cancer. A Southeastern Cancer Study Group Trial. Oncology 46:357-9
Einhorn, L H; Crawford, J; Birch, R et al. (1988) Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer. J Clin Oncol 6:451-6
Loehrer Sr, P J; Williams, S D; Einhorn, L H (1988) Testicular cancer: the quest continues. J Natl Cancer Inst 80:1373-82
Loehrer Sr, P J; Birch, R; Kramer, B S et al. (1986) Ifosfamide plus N-acetylcysteine in the treatment of small cell and non-small cell carcinoma of the lung: a Southeastern Cancer Study Group Trial. Cancer Treat Rep 70:919-20
Walther, P J; Williams, S D; Troner, M et al. (1986) Phase II study of etoposide for carcinoma of the prostate. Cancer Treat Rep 70:771-2

Showing the most recent 10 out of 15 publications